ESC 365 - State of the art lecture - when is the time to implement novel biomarkers routinely?

ESC Professional Premium Access

State of the art lecture - when is the time to implement novel biomarkers routinely?

Session: When is the time to implement novel biomarkers routinely?

Topic: Biomarkers

Speaker: Professor B. Ference (Cambridge, GB)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

32 presentations

9 followers

3 more presentations in this session

Plasma amyloid-beta levels and risk of new-onset atrial fibrillation in the general population

Speaker: Mr Z. Lu (Beijing, CN)

Association of fatal and non-fatal adverse health outcomes with urinary peptides reflecting collagen I turnover

Speaker: Doctor J. Melgarejo (Leuven, BE)

Panel discussion.

Access the full session

When is the time to implement novel biomarkers routinely?

Speakers: Professor B. Ference, Mr Z. Lu, Doctor J. Melgarejo

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources